Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: J Mol Med (Berl). 2018 May 5;96(6):575–583. doi: 10.1007/s00109-018-1642-9

Fig. 1. Survival was improved in BDL treated with emricasan in long-term BDL.

Fig. 1.

(a) Experimental design. (b) Liver pictures in control group and BDL group. Scale bar, 50 mm. (c) ratio of liver weight / body weight in control group and BDL group. ***p<0.001. (d) Survival curve in control group and BDL group *p<0.05. Values are mean ± SEM.